Gabay Avraham

Reported to SECin USFilings at 2 companies

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 3 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

3
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
ORAMED PHARMACEUTICALS INC.Chief Financial OfficerAward—209,291 sharesSep 25, 2026ORAMED PHARMACEUTICALS INC.Chief Financial Officer—Award · Sep 25Award209,291Sep 25, 2026
Lifeward Ltd.—Awardnothing paid13,643 sharesAug 24, 2026Lifeward Ltd.nothing paidAward · Aug 24Award13,643Aug 24, 2026
ORAMED PHARMACEUTICALS INC.Chief Financial OfficerOpen-market sell$330,74473,360 sharesJul 2, 2026ORAMED PHARMACEUTICALS INC.Chief Financial Officer$330,744Sell · Jul 2Open-market sell73,360Jul 2, 2026